BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8996276)

  • 1. Stevens-Johnson syndrome associated with topical nitrogen mustard therapy.
    Newman JM; Rindler JM; Bergfeld WF; Brydon JK
    J Am Acad Dermatol; 1997 Jan; 36(1):112-4. PubMed ID: 8996276
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
    Liner K; Brown C; McGirt LY
    Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
    Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
    JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
    Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
    Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
    Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycosis fungoides and infantile xanthogranuloma treated with topical flupamesone].
    Pereiro Miguens M
    Actas Dermosifiliogr; 1977; 68(12):83-90. PubMed ID: 404849
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination topical nitrogen mustard and photochemotherapy for mycosis fungoides.
    Monk BE; Vollum DI; du Vivier AW
    Clin Exp Dermatol; 1984 May; 9(3):243-7. PubMed ID: 6733953
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
    Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
    J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
    Lindahl LM; Fenger-Grøn M; Iversen L
    Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical chemotherapy of mycosis fungoides.
    Grekin DA; Zackheim HS; Epstein EH
    Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides, nitrogen mustard and skin cancer.
    Du Vivier A; Vonderheid EC; Van Scott EJ; Urbach F
    Br J Dermatol; 1978 Jul; 99(1):61-3. PubMed ID: 678466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
    Thestrup-Pedersen K; Christiansen JV; Zachariae H
    Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of early cutaneous T-cell lymphoma.
    Ramsay DL; Meller JA; Zackheim HS
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
    Hamminga B; Noordijk EM; van Vloten WA
    Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
    Price NM
    Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can cutaneous intolerance reactions to caryolysine be prevented or controlled?].
    Ann Dermatol Venereol; 1997; 124(9):662-4. PubMed ID: 9739933
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.